315 related articles for article (PubMed ID: 35378193)
1. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.
Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X
J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
Yin B; Bi YM; Fan GJ; Xia YQ
J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.
Li X; Wei S; Niu S; Ma X; Li H; Jing M; Zhao Y
Comput Biol Med; 2022 May; 144():105389. PubMed ID: 35303581
[TBL] [Abstract][Full Text] [Related]
5. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis.
Liang J; Huang Y; Mai Z; Zhan Q; Lin H; Xie Y; Wang H; Liu Y; Luo C
Drug Des Devel Ther; 2021; 15():1779-1795. PubMed ID: 33958856
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.
Yang J; Tang C; Jin R; Liu B; Wang P; Chen Y; Zeng C
Sci Rep; 2022 Apr; 12(1):5526. PubMed ID: 35365737
[TBL] [Abstract][Full Text] [Related]
8. Utilizing network pharmacology, molecular docking, and animal models to explore the therapeutic potential of the WenYang FuYuan recipe for cerebral ischemia-reperfusion injury through AGE-RAGE and NF-κB/p38MAPK signaling pathway modulation.
Zhang D; Qin H; Chen W; Xiang J; Jiang M; Zhang L; Zhou K; Hu Y
Exp Gerontol; 2024 Jun; 191():112448. PubMed ID: 38697555
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of mijianchangpu decoction on ischemic stroke through components accessing to the brain based on network pharmacology.
Zhao X; Liu J; Yang L; Niu Y; Ren R; Su C; Wang Y; Chen J; Ma X
J Ethnopharmacol; 2022 Mar; 285():114882. PubMed ID: 34848358
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification.
YingHuang ; Gao SS; Gong ZH; Li WJ; Xiao-junGou ; Sun JJ; Sun MJ
Biomed Res Int; 2022; 2022():7759402. PubMed ID: 35097126
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of angiogenesis-promoting components in Huanglian Jiedu decoction using live cell bio-specific extraction.
Liao F; He D; Liu C; Vong CT; Zhong Z; Wang Y
J Ethnopharmacol; 2023 Mar; 303():115961. PubMed ID: 36442757
[TBL] [Abstract][Full Text] [Related]
12. Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology.
Gong Z; Li R; Chen S; Wu H; Cai Y; Li J; Zhao X; Chu Q; Luo C; Qing L; Li N; Wu W
J Healthc Eng; 2022; 2022():2457706. PubMed ID: 36061816
[TBL] [Abstract][Full Text] [Related]
13. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway.
Wang PR; Wang JS; Zhang C; Song XF; Tian N; Kong LY
J Ethnopharmacol; 2013 Aug; 149(1):270-80. PubMed ID: 23811213
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics-based mechanisms exploration of Huang-Lian Jie-Du decoction on cerebral ischemia via UPLC-Q-TOF/MS analysis on rat serum.
Zhu B; Cao H; Sun L; Li B; Guo L; Duan J; Zhu H; Zhang Q
J Ethnopharmacol; 2018 Apr; 216():147-156. PubMed ID: 29360497
[TBL] [Abstract][Full Text] [Related]
15. Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12.
Lin J; Gu M; Wang X; Chen Y; Chau NV; Li J; Chu Q; Qing L; Wu W
J Ethnopharmacol; 2024 Jun; 328():118125. PubMed ID: 38561055
[TBL] [Abstract][Full Text] [Related]
16. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the underlying mechanism of Buyang Huanwu decoction in ischemic stroke by integrating systems pharmacology-proteomics and in vivo experiments.
Liao W; Wang P; He Y; Liu Z; Wang L
Fitoterapia; 2024 Jun; 175():105935. PubMed ID: 38580032
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification.
Li R; Lou Q; Ji T; Li Y; Yang H; Ma Z; Zhu Y; Qian C; Yang W; Wang Y; Luo S
J Ethnopharmacol; 2024 Jul; 329():118157. PubMed ID: 38588987
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke.
Cui Q; Zhang YL; Ma YH; Yu HY; Zhao XZ; Zhang LH; Ge SQ; Zhang GW; Qin XD
J Ethnopharmacol; 2020 Jul; 257():112891. PubMed ID: 32315738
[TBL] [Abstract][Full Text] [Related]
20. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study.
Wu W; Zhang Y; Liu G; Chi Z; Zhang A; Miao S; Lin C; Xu Q; Zhang Y
Open Med (Wars); 2023; 18(1):20230746. PubMed ID: 37533739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
